Tyra Biosciences Inc
(TYRA)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 241,701 | 251,213 | 263,211 | 275,107 | 292,499 |
| TOTAL | $246,709 | $257,288 | $267,471 | $277,299 | $294,025 |
| Non-Current Assets | |||||
| PPE Net | 1,048 | 1,077 | 1,146 | 1,201 | 1,008 |
| Other Non-Current Assets | 7,298 | 7,816 | 7,368 | 8,618 | 3,938 |
| TOTAL | $8,346 | $8,893 | $8,514 | $9,819 | $4,946 |
| Total Assets | $255,055 | $266,181 | $275,985 | $287,118 | $298,971 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,280 | 1,145 | 2,747 | 2,343 | 1,356 |
| Accrued Expenses | 2,258 | 4,416 | 2,615 | 2,989 | 3,426 |
| TOTAL | $3,682 | $5,701 | $5,489 | $5,455 | $4,901 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 2,583 | 2,651 | 2,740 | 2,810 | 2,886 |
| TOTAL | $2,583 | $2,651 | $2,740 | $2,810 | $2,886 |
| Total Liabilities | $6,265 | $8,352 | $8,229 | $8,265 | $7,787 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 42,562 | 42,436 | 42,197 | 41,974 | 41,761 |
| Common Shares | 4 | 4 | 4 | 4 | 4 |
| Retained earnings | -107,576 | -95,696 | -82,801 | -70,292 | -55,197 |
| TOTAL | $248,790 | $257,829 | $267,756 | $278,853 | $291,184 |
| Total Liabilities And Equity | $255,055 | $266,181 | $275,985 | $287,118 | $298,971 |